November 9-11, 2020 | Virtual Conference


Scott Tomsky

VP, North America
Regulatory Affairs, Generics, Teva

Scott D. Tomsky is currently Vice President, Regulatory Affairs, Generics, North America for TEVA and is based in Horsham, Pa.
Prior to joining Teva, the world’s leading provider of generic medicines in July 2013, Scott worked for Ranbaxy in Princeton, NJ for nearly 12 years. While at Ranbaxy Scott held several positions in RA and when he left he was head of Regulatory Affairs and Pharmacovigilance for North America. Scott has also worked at Johnson & Johnson in Regulatory Affairs at McNeil, and over his 20 years in the industry has also held positions in R&D and Quality.

His regulatory experience includes filings and strategy for DMFs, ANDAs, and NDAs. He has experience with many dosage forms including steriles, solids, liquids, transdermals, inhalation products, and drug-device combination products. In addition, Scott has worked closely with cross functional teams on compliance matters, as well as pharmacovigilance activities.

Scott has been actively involved in AAM and served on the AAM GDUFA II negotiating team. He also remains closely involved with GDUFA II implementation as a member of the AAM implementation team. He holds a B.S. in Biology and a Minor in Chemistry from Trenton State College in NJ and a M.S. in Quality Assurance and Regulatory Affairs from Temple University.

Skip to content